FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung CancerPRNewsWire • 12/13/23
5 Sizzling Wall Street ‘Strong Buy” Stocks Are Also Raising Their Dividends This Week24/7 Wall Street • 12/06/23
Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/30/23
Amgen Inc. (AMGN) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)Seeking Alpha • 11/29/23
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of tradeMarket Watch • 11/22/23